We performed a second-generation genome-wide association study of 4,533 individuals with
celiac disease (cases) and 10,750 control subjects. We genotyped 113 selected SNPs with …

Objectives: The ESPGHAN 2012 coeliac disease (CD) diagnostic guidelines aimed to guide
physicians in accurately diagnosing CD and permit omission of duodenal biopsies in …

Using variants from the 1000 Genomes Project pilot European CEU dataset and data from
additional resequencing studies, we densely genotyped 183 non-HLA risk loci previously …

We tested 310,605 SNPs for association in 778 individuals with celiac disease and 1,422
controls. Outside the HLA region, the most significant finding (rs13119723; P = 2.0 × 10 −7 ) …

Our genome-wide association study of celiac disease previously identified risk variants in
the IL2–IL21 region. To identify additional risk variants, we genotyped 1,020 of the most …

Background A window of opportunity has been suggested for reducing the risk of celiac
disease by introducing gluten to infants at 4 to 6 months of age. Methods We performed a …

Celiac disease is caused by a selective lack of T cell tolerance for gluten. It is known that the
enzyme tissue transglutaminase (tTG) is involved in the generation of T cell stimulatory …

Coeliac disease is an immune-mediated enteropathy against dietary gluten present in wheat,
rye and barley and is one of the most common lifelong food-related disorders worldwide. …

Background & Aims The guidelines of the European Society of Pediatric Gastroenterology,
Hepatology, and Nutrition allow for diagnosis of celiac disease without biopsies in children …

Objective To investigate the value of serum antitissue transglutaminase IgA antibodies (IgA-TTG)
and IgA antiendomysial antibodies (IgA-EMA) in the diagnosis of coeliac disease in …